147 related articles for article (PubMed ID: 38229092)
1. USP5 facilitates bladder cancer progression by stabilizing the c-Jun protein.
Zhang HH; Zhang AQ; Peng P; Huang L; Liu CY; Nie XR; Hou DF; Zhang X; Li SZ
Cancer Cell Int; 2024 Jan; 24(1):32. PubMed ID: 38229092
[TBL] [Abstract][Full Text] [Related]
2. USP5 promotes epithelial-mesenchymal transition by stabilizing SLUG in hepatocellular carcinoma.
Meng J; Ai X; Lei Y; Zhong W; Qian B; Qiao K; Wang X; Zhou B; Wang H; Huai L; Zhang X; Han J; Xue Y; Liang Y; Zhou H; Chen S; Sun T; Yang C
Theranostics; 2019; 9(2):573-587. PubMed ID: 30809294
[No Abstract] [Full Text] [Related]
3. Ubiquitin specific peptidase 5 regulates colorectal cancer cell growth by stabilizing Tu translation elongation factor.
Xu X; Huang A; Cui X; Han K; Hou X; Wang Q; Cui L; Yang Y
Theranostics; 2019; 9(14):4208-4220. PubMed ID: 31281542
[TBL] [Abstract][Full Text] [Related]
4. USP5 Promotes Uterine Corpus Endometrial Carcinoma Cell Growth and Migration via mTOR/4EBP1 Activation.
Li Y; Zhou J
Cancer Manag Res; 2021; 13():3913-3924. PubMed ID: 34012297
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinase USP5 promotes non-small cell lung cancer cell proliferation by stabilizing cyclin D1.
Zhang Z; Cui Z; Xie Z; Li C; Xu C; Guo X; Yu J; Chen T; Facchinetti F; Bohnenberger H; Leong TL; Xie Y; Mao X; Zhao J
Transl Lung Cancer Res; 2021 Oct; 10(10):3995-4011. PubMed ID: 34858787
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-specific peptidase 5 facilitates cancer stem cell-like properties in lung cancer by deubiquitinating β-catenin.
Tung CH; Wu JE; Huang MF; Wang WL; Wu YY; Tsai YT; Hsu XR; Lin SH; Chen YL; Hong TM
Cancer Cell Int; 2023 Sep; 23(1):207. PubMed ID: 37726816
[TBL] [Abstract][Full Text] [Related]
7. Ubiquitin-specific protease 5 promotes bladder cancer progression through stabilizing Twist1.
Cai H; Ke ZB; Chen JY; Li XD; Zhu JM; Xue YT; Ruan ZT; Wang Z; Lin F; Zheng QS; Wei Y; Xue XY; Xu N
Oncogene; 2024 Mar; 43(10):703-713. PubMed ID: 38218898
[TBL] [Abstract][Full Text] [Related]
8. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinase inhibitor degrasyn suppresses metastasis by targeting USP5-WT1-E-cadherin signalling pathway in pancreatic ductal adenocarcinoma.
Li J; Li H; Zhu W; Zhou B; Ying J; Wu J; Zhang H; Sun H; Gao S
J Cell Mol Med; 2020 Jan; 24(2):1370-1382. PubMed ID: 31845546
[TBL] [Abstract][Full Text] [Related]
10. USP5 promotes tumorigenesis and progression of pancreatic cancer by stabilizing FoxM1 protein.
Li XY; Wu HY; Mao XF; Jiang LX; Wang YX
Biochem Biophys Res Commun; 2017 Oct; 492(1):48-54. PubMed ID: 28807830
[TBL] [Abstract][Full Text] [Related]
11. DEPDC1B-mediated USP5 deubiquitination of β-catenin promotes breast cancer metastasis by activating the wnt/β-catenin pathway.
Wang Q; Chen F; Yang N; Xu L; Yu X; Wu M; Zhou Y
Am J Physiol Cell Physiol; 2023 Oct; 325(4):C833-C848. PubMed ID: 37642235
[TBL] [Abstract][Full Text] [Related]
12. Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression.
Liu T; Fan MQ; Xie XX; Shu QP; Du XH; Qi LZ; Zhang XD; Zhang MH; Shan G; Du RL; Li SZ
J Transl Med; 2023 Sep; 21(1):656. PubMed ID: 37740194
[TBL] [Abstract][Full Text] [Related]
13. USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1.
Li G; Yang T; Chen Y; Bao J; Wu D; Hu X; Feng C; Xu L; Li M; Li G; Jin M; Xu Y; Zhang R; Qian G; Pan J
Front Pharmacol; 2021; 12():720307. PubMed ID: 34483932
[TBL] [Abstract][Full Text] [Related]
14. Ubiquitin specific peptidase 5 promotes ovarian cancer cell proliferation through deubiquitinating HDAC2.
Du Y; Lin J; Zhang R; Yang W; Quan H; Zang L; Han Y; Li B; Sun H; Wu J
Aging (Albany NY); 2019 Nov; 11(21):9778-9793. PubMed ID: 31727867
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin specific peptidase 5 enhances STAT3 signaling and promotes migration and invasion in Pancreatic Cancer.
Lian J; Liu C; Guan X; Wang B; Yao Y; Su D; Ma Y; Fang L; Zhang Y
J Cancer; 2020; 11(23):6802-6811. PubMed ID: 33123271
[No Abstract] [Full Text] [Related]
16. USP5 facilitates diabetic retinopathy development by stabilizing ROBO4 via deubiquitination.
Guo H; Liu R; Lv H; Huo Q; Yao Y; Lu X
Cell Signal; 2024 Aug; 120():111225. PubMed ID: 38735506
[TBL] [Abstract][Full Text] [Related]
17. A pan-cancer analysis of the role of USP5 in human cancers.
Yan B; Guo J; Deng S; Chen D; Huang M
Sci Rep; 2023 Jun; 13(1):8972. PubMed ID: 37268697
[TBL] [Abstract][Full Text] [Related]
18. USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway.
Cao L; Liu H; Huang C; Guo C; Zhao L; Gao C; Xu Y; Wang G; Liang N; Li S
Biol Direct; 2023 Apr; 18(1):16. PubMed ID: 37060095
[TBL] [Abstract][Full Text] [Related]
19. USP5 promotes tumorigenesis by activating Hedgehog/Gli1 signaling pathway in osteosarcoma.
Wu Q; Liu R; Yang Y; Peng J; Huang J; Li Z; Huang K; Zhu X
Am J Cancer Res; 2024; 14(3):1204-1216. PubMed ID: 38590401
[TBL] [Abstract][Full Text] [Related]
20. miR-125a suppresses malignancy of multiple myeloma by reducing the deubiquitinase USP5.
Wu L; Zhang C; Chu M; Fan Y; Wei L; Li Z; Yao Y; Zhuang W
J Cell Biochem; 2020 Jan; 121(1):642-650. PubMed ID: 31452281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
